Untitled Document

Appendix Table 1.
Summary of Medicaid prescription drug policies in states that are included in the CTS survey (as of October, 2001).



  State has any preauthorization requirement State requires copayment State has limits on the number of prescriptions State has "step-therapy" requirement State law requires use of generics
Alabama Yes Yes No No No
Arkansas Yes Yes Yes Yes No
California No Yes Yes No Yes
Connecticut No No No No No
D.C. Yes Yes No Yes Yes
Florida Yes No Yes No Yes
Georgia Yes Yes Yes No No
Illinois No No Yes No No
Indiana No Yes No Yes Yes
Kentucky Yes No No No Yes
Louisiana No Yes No Yes No
Maine Yes Yes No No No
Maryland Yes Yes No No No
Massachusetts Yes Yes No No No
Michigan Yes Yes No No No
Minnesota Yes No No Yes Yes
Missouri Yes Yes No No No
Nevada Yes No Yes No Yes
New Jersey Yes No No No Yes
New York Yes Yes Yes No No
North Carolina Yes Yes Yes No Yes
Oregon Yes No No No No
Pennsylvania Yes Yes No No No
South Carolina Yes Yes Yes No Yes
Utah Yes Yes No Yes No
Virginia No Yes No Yes No
Washington No No No Yes No
West Virginia Yes Yes Yes Yes Yes

Adapted from Schwalberg et al., Medicaid Outpatient Prescription Drug Benefits: Findings from a National Survey and Selected Case Study Highlights. Study sponsored by Kaiser Family Foundation, October, 2001.

Note: States that are in the CTS household survey but did not respond to the survey of Medicaid prescription drug benefits are: Arizona, Colorado, Ohio, Oklahoma, Tennessee, Texas, and Wisconsin.